Open original FDA record ↗Recall record
- FDA identifier
- Z-1328-2024
- Company in FDA record
- Randox Laboratories Ltd.
- FDA classification date
- Mar 20, 2024
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The firm has realigned C3 and Haptoglobin in Liquid Protein Calibrators, IT2691, to reference material ERM-DA470k/IFCC.
Source facts
- Action
- Consignees were sent a MEDICAL DEVICE CORRECTION NOTIFICATION dated 03/06/2024. The notification instructs consignees to review results generated with the affected batches in line with the clinical profile of the patient, discuss the contents of the provided recall notice with the facility's Medical Director, and complete and return the response form to technical.services@randox.com within five working days. The notice should be shared with all customers if product was further distributed and to those who need to be aware within consignee organizations. Consignees with questions should reach out to Randox Technical Services.
- Initiated
- 2024-03-01
- Root cause
- Under Investigation by firm
- Distribution
- Domestic: CA, FL, IL, ME, NJ, OH, & OR.
- Recall number
- Z-1328-2024
- Recall status
- Open, Classified
- CDRH record ID
- 206534
- FDA classified
- 2024-03-20
- Recall event number
- 94187